← Back to Search

Metastic or locally advanced cancer for Cancer

N/A
Recruiting
Research Sponsored by AIDS Malignancy Consortium
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.

Eligible Conditions
  • Cancer
  • Lymphoma
  • Anal Cancer
  • HPV-Related Malignancy
  • Human Immunodeficiency Virus Infection
  • Kaposi Sarcoma
  • Malignant Neoplasm

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Malignant Neoplasms
Secondary outcome measures
Proportion of participants eligible for AMC trials who are successfully enrolled
Other outcome measures
Malignant Neoplasms
Malignant Neoplasms
Malignant Neoplasms
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Prior cancerExperimental Treatment1 Intervention
Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy.
Group II: New, primary or recurrent diseaseExperimental Treatment2 Interventions
Considering or currently receiving cancer treatment
Group III: Metastic or locally advanced cancerExperimental Treatment2 Interventions
This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,280 Total Patients Enrolled
AIDS Malignancy ConsortiumLead Sponsor
63 Previous Clinical Trials
8,909 Total Patients Enrolled
~347 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top